Abstract
Transcription factor EB (TFEB) plays a crucial role in lipid metabolism and is indispensable for maintaining intracellular metabolic homeostasis. Its functionality relies significantly on its subcellular localization and transcriptional activity. Recent studies have revealed that SUMOylation regulates the subcellular localization and transcriptional activity of TFEB. Numerous studies indicate that mutations or dysfunctions of TFEB SUMOylation sites, as vital regulatory mechanisms, are closely associated with lipid metabolism in cardiovascular disease. Thus, in this review, we provide an overview of the current knowledge and recent advances in TFEB SUMOylation, with a particular focus on the mechanism of TFEB SUMOylation and its role in lipid metabolism, providing potential new strategies for developing novel therapeutic treatments for cardiovascular diseases.
| Original language | English |
|---|---|
| Article number | 347 |
| Number of pages | 15 |
| Journal | International Journal of Molecular Sciences |
| Volume | 27 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- SUMOylation
- cardiovascular diseases
- lipid metabolism
- transcription factor EB
Fingerprint
Dive into the research topics of 'New insights into TFEB SUMOylation and its role in lipid metabolism and cardiovascular disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver